Pharmacology News and Research

Latest Pharmacology News and Research

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena, Inc., a clinical stage biopharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the publication of its Phase 1b data for TRV130 in the journal Pain.

24 Jun 2014

Pew, Stewart Trust announce new scholars program for cancer research

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology.

24 Jun 2014

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

24 Jun 2014

Clusters of protein linked to cancer warp cell membranes

Supercomputer simulations have shown that clusters of a protein linked to cancer warp cell membranes, according to scientists at The University of Texas Health Science Center at Houston (UTHealth) Medical School.

24 Jun 2014

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

Complementary medicines are generally being defined as medicines which are non-mainstream medicines and are mostly given together with conventional medicines.

23 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

New strategy for treating neuroblastoma using modified version of heparin

Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.

18 Jun 2014

Failing dopamine pump damages brain cells of patients with Parkinson's disease

A study group at the Medical University of Vienna's Centre for Brain Research has investigated the function of an intracellular dopamine pump in Parkinson's patients compared to a healthy test group.

18 Jun 2014

Gluten-free diet can improve 'brain fog' in individuals with celiac disease

Individuals with celiac disease often experience 'brain fog' in addition to intestinal problems, but a new study shows that adhering to a gluten-free diet can lead to improvements in cognition that correlate with the extent of intestinal healing.

17 Jun 2014

Novel microscopy technology helps detect protein that plays key role in prostate cancer

Assemblies of proteins, known as protein complexes, have important functions in cells; protein complexes embedded in the cell membrane, for example, are responsible for the exchange with the extracellular environment.

16 Jun 2014

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

In a remarkable series of experiments on a fungus that causes cryptococcal meningitis, a deadly infection of the membranes that cover the spinal cord and brain, investigators at UC Davis have isolated a protein that appears to be responsible for the fungus' ability to cross from the bloodstream into the brain.

13 Jun 2014

Excessive abuse of alcohol causes structural damage at molecular level to the brain

Joint research between the University of the Basque Country (UPV/EHU) and the University of Nottingham has identified, for the first time, the structural damage caused at a molecular level to the brain by the chronic excessive abuse of alcohol.

13 Jun 2014

Proteins causing daytime sleepiness also play crucial role in bone formation

Orexin proteins, which are blamed for spontaneous daytime sleepiness, also play a crucial role in bone formation, according to findings by UT Southwestern Medical Center researchers.

13 Jun 2014

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments

Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.

11 Jun 2014

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Researchers at the Center of Excellence in Environmental Toxicology, Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences over the next four years to study asbestos exposure pathways that lead to mesothelioma, the bioremediation of this hazardous material, and mechanisms that lead to asbestos-related diseases.

10 Jun 2014

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.

9 Jun 2014

Study defines how our ability to identify spatial acuity varies across the body

"Where does it hurt?" is the first question asked to any person in pain. A new UCL study defines for the first time how our ability to identify where it hurts, called "spatial acuity", varies across the body, being most sensitive at the forehead and fingertips.

9 Jun 2014

Pharmacology News and Research

Latest Pharmacology News and Research

Trevena's Phase 1b data for TRV130 published in the journal Pain

Pew, Stewart Trust announce new scholars program for cancer research

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Clusters of protein linked to cancer warp cell membranes

Complementary medicines: an interview with Associate Professor Evelin Tiralongo, Griffith University

New driver of atherosclerosis may prove to be promising therapeutic target

New strategy for treating neuroblastoma using modified version of heparin

Failing dopamine pump damages brain cells of patients with Parkinson's disease

Gluten-free diet can improve 'brain fog' in individuals with celiac disease

Novel microscopy technology helps detect protein that plays key role in prostate cancer

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Excessive abuse of alcohol causes structural damage at molecular level to the brain

Proteins causing daytime sleepiness also play crucial role in bone formation

Scientists discover important new biomarker that could improve HER2 targeted cancer treatments

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Advances in understanding of genetics of CAD lead to more therapeutic targets

Study defines how our ability to identify spatial acuity varies across the body

Researchers find that protein serves as on-off switch for "beigeing" of fat

Lack of O2 in fat cells triggers inflammation and insulin resistance in obesity

New gene involved in Parkinson's disease, find researchers

Pittcon Highlights: Pharmaceutical & Biologic eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in